Suzette Delaloge (S Delaloge)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 22

Top Topics

Metastatic Breast Cancer

Angiotensin Converting Enzyme

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Alice B Franzoi, Lena Degousée, Elise Martin, Patricia Miguel Semedo, Marion Aupomerol, Davide Soldato, Antonio Di Meglio, Camila Chiodi, Aude Barbier, Hajer Chaouachi, Nathalie Renvoisé, Diane Boinon, Léonor Fasse, Joana Mourato Ribeiro, Jean Bernard Le-Provost, Johanna Arvis, Céline Lazorthes, Mario Di Palma, Anne de Jesus, Bruno Raynard, Arnaud Pagès, Suzette Delaloge, Barbara Pistilli, Florian Scotté, Ines Vaz Luis
Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer. JCO oncology practice 19 (6) (2023)
Alison Antoine, David Pérol, Mathieu Robain, Suzette Delaloge, Christine Lasset, Youenn Drouet
Target trial emulation to assess real-world efficacy in the ESME metastatic breast cancer cohort. Journal of the National Cancer Institute (2023)
Diana Bello Roufai, A Gonçalves, T De La Motte Rouge, S Akla, C Blonz, J Grenier, J Gligorov, M Saghatchian, C Bailleux, H Simon, I Desmoulins, Z Tharin, E Renaud, M Bertho, M-A Benderra, Suzette Delaloge, L Robert, P Cottu, J Y Pierga, D Loirat, A Bertucci, B Renouf, Francois-Clement Bidard, F Lerebours
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program. Oncogene (2023)
Fabiola Giudici, Barbara Pistilli, Ines Vaz-Luis, Maryam Karimi, Suzette Delaloge, Thomas Bachelot, Stefan Michiels, Aurelie Bardet
Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer. British journal of cancer (2023)
Sara M Tolaney, Arlene Chan, Katarina Petrakova, Suzette Delaloge, Mario Campone, Hiroji Iwata, Parvin F Peddi, Peter A Kaufman, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen, Gautier Paux, Lei Wang, Nils Ternès, Eric Boitier, Seock-Ah Im
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jean-Sébastien Frenel, A Lusque, Suzette Delaloge, J-M Ferrero, Thomas Bachelot, I Desmoulins, C Levy, J-C Eymard, A Gonçalves, Anne Patsouris, M A Mouret Reynier, M J-C Thery, T Petit, Luc Cabel, L Uwer, M Debled, M Chevrot, A Mailliez, William Jacot, T de La Motte Rouge
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation. British journal of cancer (2023)
Diana Bello Roufai, A Gonçalves, T De La Motte Rouge, S Akla, C Blonz, J Grenier, J Gligorov, M Saghatchian, C Bailleux, H Simon, I Desmoulins, Z Tharin, E Renaud, M Bertho, M-A Benderra, Suzette Delaloge, L Robert, P Cottu, J Y Pierga, D Loirat, A Bertucci, B Renouf, Francois-Clement Bidard, F Lerebours
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program. Oncogene (2023)
Diana Bello Roufai, A Gonçalves, T De La Motte Rouge, S Akla, C Blonz, J Grenier, J Gligorov, M Saghatchian, C Bailleux, H Simon, I Desmoulins, Z Tharin, E Renaud, M Bertho, M-A Benderra, Suzette Delaloge, L Robert, P Cottu, J Y Pierga, D Loirat, A Bertucci, B Renouf, Francois-Clement Bidard, F Lerebours
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program. Oncogene (2023)
Voichita Suciu, Carolla El Chamieh, Ranya Soufan, Marie-Christine Mathieu, Corinne Balleyguier, Suzette Delaloge, Zsofia Balogh, Jean Yves Scoazec, Sylvie Chevret, Philippe Vielh
Real-World Diagnostic Accuracy of the On-Site Cytopathology Advance Report (OSCAR) Procedure Performed in a Multidisciplinary One-Stop Breast Clinic. Cancers 15 (20) (2023)
Diana Bello Roufai, A Gonçalves, T De La Motte Rouge, S Akla, C Blonz, J Grenier, J Gligorov, M Saghatchian, C Bailleux, H Simon, I Desmoulins, Z Tharin, E Renaud, M Bertho, M-A Benderra, Suzette Delaloge, L Robert, P Cottu, J Y Pierga, D Loirat, A Bertucci, B Renouf, Francois-Clement Bidard, F Lerebours
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program. Oncogene (2023)
Jordi Rodon Ahnert, Pauline Funchain, Theodore W Laetsch, Hendrick-Tobias Arkenau, Alice Hervieu, Christian F Singer, Yonina R Murciano-Goroff, Sant P Chawla, Kristin Anthony, Ikuo Yamamiya, Mei Liu, Abdel-Baset Halim, Karim A Benhadji, Osamu Takahashi, Suzette Delaloge
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN -inactivating mutations. Future oncology (London, England) 18 (30) (2022)
Antonio Di Meglio, Julie Havas, Arnauld S Gbenou, Elise Martin, Mayssam El-Mouhebb, Barbara Pistilli, Gwenn Menvielle, Agnes Dumas, Sibille Everhard, Anne-Laure Martin, Paul-Henri Cottu, Florence Lerebours, Charles Coutant, Anne Lesur, Olivier Trédan, Patrick Soulie, Laurence Vanlemmens, Florence Joly Lobbedez, Suzette Delaloge, Patricia A Ganz, Fabrice Andre, Ann H Partridge, Lee W Jones, Stefan Michiels, Ines Vaz Luis
Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Ines Vaz Luis, Antonio Di Meglio, Julie Havas, Mayssam El-Mouhebb, Pietro Lapidari, Daniele Presti, Davide Soldato, Barbara Pistilli, Agnes Dumas, Gwenn Menvielle, Cécile Charles, Sibille Everhard, Anne-Laure Martin, Paul-Henri Cottu, Florence Lerebours, Charles Coutant, Sarah Dauchy, Suzette Delaloge, Nancy U Lin, Patricia A Ganz, Ann H Partridge, Fabrice Andre, Stefan Michiels
Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Thomas Bachelot, Paul-Henri Cottu, Sylvie Chabaud, Florence Dalenc, Djelila Allouache, Suzette Delaloge, Jean-Philippe Jacquin, Julien Grenier, Laurence Venat Bouvet, Apurna Jegannathen, Mario Campone, Francesco Del Piano, Marc Debled, Anne-Claire Hardy-Bessard, Sylvie Giacchetti, Marie-Ange Mouret-Reynier, Philippe Barthelemy, Laure Kaluzinski, Audrey Mailliez, Eric Legouffe, Matthew Sephton, Judith M Bliss, Jean-Luc Canon, Frédérique M Penault-Llorca, Jérôme Lemonnier, David A Cameron, Fabrice Andre
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (32) (2022)
Antonio Di Meglio, Julie Havas, Davide Soldato, Daniele Presti, Elise Martin, Barbara Pistilli, Gwenn Menvielle, Agnes Dumas, Cécile Charles, Sibille Everhard, Anne-Laure Martin, Charles Coutant, Carole Tarpin, Laurence Vanlemmens, Christelle Levy, Olivier Rigal, Suzette Delaloge, Nancy U Lin, Patricia A Ganz, Ann H Partridge, Fabrice Andre, Stefan Michiels, Ines Vaz Luis
Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2022)
Olivier Mir, Marie Ferrua, Aude Fourcade, Delphine Mathivon, Adeline Duflot-Boukobza, Sarah Dumont, Eric Baudin, Suzette Delaloge, David Malka, Laurence Albiges, Patricia Pautier, Caroline Robert, David Planchard, Stéphane de Botton, Florian Scotté, François Lemare, May Abbas, Marilène Guillet, Vanessa Puglisi, Mario Di Palma, Etienne Minvielle
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial. Nature medicine 28 (6) (2022)
William Jacot, Amélie Lusque, Cécile Vicier, Audrey Mailliez, Thibault de La Motte Rouge, Luc Cabel, Christelle Levy, Anne Patsouris, Isabelle Desmoulins, Lionel Uwer, Jean-Christophe Thery, Mathieu Robain, Olivier Caron, Olivier Tredan, Thomas Filleron, Jean-Sébastien Frenel, Suzette Delaloge
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations. British journal of cancer 127 (11) (2022)
Lucie Veron, Delphine Wehrer, Gisèle Annerose-Zéphir, Voichita Suciu, Suzette Delaloge, Barbara Pistilli, Dan Chaltiel, Patricia Pautier
Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up. Breast cancer research and treatment 188 (2) (2021)
Alexandra Bizot, Maryam Karimi, Elie Rassy, Pierre Etienne Heudel, Christelle Levy, Laurence Vanlemmens, Catherine Uzan, Elise Deluche, Dominique Genet, Mahasti Saghatchian, Sylvie Giacchetti, Juline Grenier, Anne Patsouris, Véronique Dieras, Jean-Yves Pierga, Thierry Petit, Sylvain Ladoire, William Jacot, Marc-Antoine Benderra, Anne De Jesus, Suzette Delaloge, Matteo Lambertini, Barbara Pistilli
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic. British journal of cancer 125 (11) (2021)
Aitziber Buque, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato, Fernando Aranda, Sylvère Durand, Alexandre Boissonnas, Jitka Fucikova, Laura Senovilla, David Enot, Michal Hensler, Margerie Kremer, Gautier Stoll, Yang Hu, Chiara Massa, Silvia C Formenti, Barbara Seliger, Olivier Elemento, Radek Spisek, Fabrice Andre, Laurence Zitvogel, Suzette Delaloge, Guido Kroemer, Lorenzo Galluzzi
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications 11 (1) (2020)
Nora Pashayan, Antonis C Antoniou, Urška Ivanuš, Laura J Esserman, Douglas F Easton, David P French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans, Jacques Simard, Montserrat Garcia-Closas, Rita Schmutzler, Odette Wegwarth, Paul D P Pharoah, Sowmiya Moorthie, Sandrine De Montgolfier, Camille Baron, Zdenko Herceg, Clare Turnbull, Corinne Balleyguier, Paolo Giorgi Rossi, Jelle Wesseling, David Ritchie, Marc Tischkowitz, Mireille Broeders, Dan Reisel, Andres Metspalu, Thomas Callender, Harry de Koning, Peter Devilee, Suzette Delaloge, Marjanka K Schmidt, Martin Widschwendter
Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nature reviews. Clinical oncology 17 (11) (2020)
Aitziber Buque, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato, Fernando Aranda, Sylvère Durand, Alexandre Boissonnas, Jitka Fucikova, Laura Senovilla, David Enot, Michal Hensler, Margerie Kremer, Gautier Stoll, Yang Hu, Chiara Massa, Silvia C Formenti, Barbara Seliger, Olivier Elemento, Radek Spisek, Fabrice Andre, Laurence Zitvogel, Suzette Delaloge, Guido Kroemer, Lorenzo Galluzzi
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications 11 (1) (2020)